Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program-Reference-Cited by-同舟云学术

Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program

Published:2018-04 Issue:1 Volume:287 Page:58-67
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Hofvind Solveig¹,Sagstad Silje¹,Sebuødegård Sofie¹,Chen Ying¹,Roman Marta¹,Lee Christoph I.¹

Affiliation:

1. From the Cancer Registry of Norway, PO 5313 Majorstuen, 0304 Oslo, Norway (S.H., S. Sagstad, S. Sebuødegård); Department of Pathology, Akershus Universitetssykehus HF, Lorenskog, Norway (Y.C.); Department of Epidemiology and Evaluation, Hospital del Mar Medical Research Institute, Barcelona, Spain (M.R.); and Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, Wash (C.I.L.).

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2017162159

Reference33 articles.

1. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers

2. Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden

3. Mode of detection: an independent prognostic factor for women with breast cancer

4. Interval cancer rates in the Irish national breast screening programme

5. Interval cancers in the Dutch breast cancer screening programme

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial interpretation scores of screening mammograms and cancer detection in BreastScreen Norway;European Journal of Radiology;2024-10

2. A Prospective Analysis of Screen-Detected Cancers Recalled and Not Recalled by Artificial Intelligence;Journal of Breast Imaging;2024-05-27

3. Breast Cancer Incidence After a False-Positive Mammography Result;JAMA Oncology;2024-01-01

4. Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway;Preventive Medicine;2023-10

5. Early screening outcomes before, during, and after a randomized controlled trial with digital breast tomosynthesis;European Journal of Radiology;2023-10